Education
School ¡X Major ¡X Degree | Duration |
---|---|
°ª¶¯Âå¾Ç¤j¾Ç ¡X Âå¾Ç¬ã¨s©Ò(²¦) ¡X ³Õ¤h Doctorate, Graduate Institute of Medicine, Kaohsiung Medical University |
2001/09 ¡X 2005/06 |
°ª¶¯Âå¾Ç°| ¡X Âå¾Ç¨t(²¦) ¡X ¾Ç¤h Bachelor, School of Medicine, Kaohsiung Medical College |
1980/09 ¡X 1987/06 |
°ª¶¯Âå¾Ç°| ¡X Âå¾Ç¨t(¸w) ¡X ¾Ç¤h Bachelor, School of Medicine, Kaohsiung Medical College |
1980/09 ¡X 1987/06 |
Intramural Experience
Office/Department/Institute | Position | Duration |
---|---|---|
G¸z¤º¬ì Division of Gastroenterology | Visiting Staff | ¡X |
¬r²z¾Ç³Õ¤h¾Ç¦ì¾Çµ{ PhD Degree Program in Toxicology | Professor | 2021/08/01 ¡X |
¬r²z¾ÇºÓ¤h¾Ç¦ì¾Çµ{ Master Degree Program in Toxicology | Professor | 2020/08/01 ¡X 2021/07/31 |
µÇŦ·ÓÅ@¾Ç¨t Department of Renal Care | Professor | 2017/02/01 ¡X 2020/07/31 |
µÇŦ·ÓÅ@¾Ç¨t Department of Renal Care | Associate Professor | 2013/03/01 ¡X 2017/01/31 |
µÇŦ·ÓÅ@¾Ç¨t Department of Renal Care | Assistant Professor | 2012/08/01 ¡X 2013/02/28 |
Á{§ÉÃľǬã¨s©Ò Graduate Institute of Clinical Pharmacy | Assistant Professor | 2010/02/01 ¡X 2012/07/31 |
¤ÑµMÃĪ«¬ã¨s©Ò Graduate Institute of Natural Products | Assistant Professor | 2009/08/01 ¡X 2009/08/01 |
µÇŦ·ÓÅ@¾Ç¨t Department of Renal Care | Assistant Professor | 2009/08/01 ¡X 2010/01/31 |
µÇŦ·ÓÅ@¾Ç¨t Department of Renal Care | Assistant Professor | 2007/08/01 ¡X 2009/07/31 |
Extramural Experience
DEPNO | Position- Office/Department/Institute | Duration |
---|---|---|
¤¤µØÂå¨Æ¬ì§Þ¤j¾ÇÂå°ÈºÞ²z¨t | §U²z±Ð±Â | 0940801 ¡X 0960731 |
Discipline
Research & Technology Platform Open to the Outside
Interested Area(s)for Interdisciplinary Research
¯f¬r¤Î§K¬Ì¾Ç¡BÃIJz¤Î¬r²z¡BG¸z¨xÁxÂå¾Ç¡BµÇŦ¾Ç¡B¤¤ÂåÃÄ
Area(s) of Expertise & Research
¯f¬r¾Ç¡B¥ÍÃĪvÀø¾Ç¡BÃĪ«¬y¦æ¯f¾Ç¡BG¸z¨xÁx¤º¬ì¾Ç¡B¤º¬ì¾Ç
Publication
NO | Publication |
---|---|
1 | ¦]À³ÄY«¯S®í¶Ç¬V©ÊªÍª¢ ¡]COVID-19¡^±Ä¥Î»·¶Z±Ð¾Ç «¬ºAªº³qÃѽҵ{¦¨®Ä¡G ¥H°ª¶¯Âå¾Ç¤j¾Ç¬°¨Ò Exploring the Effect of General Education Courses Using Distance Teaching Format in Response to the COVID-19: A case of Kaohsiung Medical University |
2 | Proton pump inhibitors reduce the survival of advanced lung cancer patients with therapy of gefitinib or erlotinib. Proton pump inhibitors reduce the survival of advanced lung cancer patients with therapy of gefitinib or erlotinib. |
3 | Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis |
4 | ÄÄ©ú¤¤ÃĪº¤À¤l¾÷¨î¡G¥H¹ï§Ü«æ©Ê®ð¹D¯f¬r·P¬Vªº°t¤è¬°¨Ò Unraveling the Molecular Mechanism of Traditional Chinese Medicine: Formulas Against Acute Airway Viral Infections as Examples. |
5 | ¨âÓ¤ë¨B¦æ©I§l§ïµ½ºC©Êªý¶ë©ÊªÍ¯f¯f¤HªºµJ¼{¡A¼~Æ{¡A©I§l§xÃø©M¥Í¬¡«~½è¡G¤@¶µÀH¾÷¹ï·Ó¬ã¨s Two-month breathing-based walking improves anxiety, depression, dyspnea, and quality of life in chronic obstructive pulmonary disease: a randomized controlled study |
6 | ¯ô³¯»U¨¾¤î¸z¯f¬r71«¬¤º¤Æ¨Ó§í¨î¨ä³y¦¨ªº²ÓM¶Ë®` Artemisia capillaris inhibited enterovirus 71-induced cell injury by preventing viral internalization |
7 | Optimal dosage and early intervention of L-ascorbic acid inhibiting K2Cr2O7- induced renal tubular cell damage Optimal dosage and early intervention of L-ascorbic acid inhibiting K 2 Cr 2 O 7-induced renal tubular cell damage |
8 | ¨Ï¥Î¤Æ¾Ç±´°wÀË´ú°¨¨Ó»Ä¤Þ°_ªºµÇ¤pºÞ·l¶Ëªº³J¥Õ½èÅé¾Ç The use of chemical probes to detect the proteomics of renal tubular injury induced by maleic acid |
9 | Transient Monocytosis Subjugates Low Platelet Count in Adult Dengue Patients Transient Monocytosis Subjugates Low Platelet Count in Adult Dengue Patients |
10 | An antibiotic decision-making tool for patients with pneumonia admitted to a medical intensive care unit An antibiotic decision-making tool for patients with pneumonia admitted to a medical intensive care unit |
11 | Gan-Lu-Siao-Du-yin, a prescription of traditional Chinese medicine, inhibited enterovirus 71 replication, translation, and virus-induced cell apoptosis Gan-Lu-Siao-Du-yin, a prescription of traditional Chinese medicine, inhibited enterovirus 71 replication, translation, and virus-induced cell apoptosis |
12 | ¦å²G³zªR¤¤¶i¦æ¦³®ñ¹B°Ê¹ï¨Åé¥\¯à©M¼~Æ{ªº¼vÅT Effects of aerobic exercise during hemodialysis on physical functional performance and depression |
13 | ®g¤z³Â¶À´ö¸g¥Ñ´î¤Ö¯f¬r§lªþ¬ï³z½Æ»sÂàĶ¨Ó§í¨î¸z¯f¬r71«¬ Yakammaoto inhibits enterovirus 71 infection with reduced viral attachment, internalization, replication, and translation. |
14 | Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease. Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease. |
15 | ±q¾Ç²ß«~½è«OÃÒ¾÷¨î¨ì½Ò«Ç±Ð¾Ç¡G°ªÂå«Ø¥ß¡u²`«×¾Ç²ß¡v¤§¨ú®| From Institutionalized Learning Quality Assurance to Classroom Teaching: KMU¡¦s Path to Create ¡§Deep Learning¡¨ |
16 | C«¬¨xª¢·P¬V¼W¥[µo®i¥½´ÁµÇŦ¯fªº·ÀI-¨Ï¥ÎÄvª§·ÀI¤ÀªR Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis |
17 | ®g¤z³Â¶À´ö¸g¥Ñ§í¨î¯f¬r§lªþ,¬ï³z,½Æ»s¨Ó§í¨î¤HÃþ§J¨F©_B4¯f¬r³y¦¨ªº©I§l¹D¤ÎµÇ¤pºÞ·l¶Ë Yakammaoto inhibited human coxsackievirus B4 (CVB4)-induced airway and renal tubular injuries by preventing viral attachment, internalization, and replication. |
18 | ¥ÍÁ¤§í¨î©I§l¹D¿Ä¦X¯f¬r·P¬VÂH½¤²ÓM Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines |
19 | ¨¢Ãħí¨î©I§l¹D¿Ä¦X¯f¬r·P¬VÂH½¤²ÓM Anti-viral activity of water extract of Paeonia lactiflora Pallas against human respiratory syncytial virus in human respiratory tract cell lines. |
20 | ¥Ì¯ó¼ö¤ô²ÊµÑ¨úª«§í¨î¤HÃþ©I§l¹D¿Ä¦X¯f¬r·P¬VÂH½¤²ÓM Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines |
21 | ¸¯®Ú¦b¤HÃþ©I§l¹D²ÓM®è§Ü¤HÃþ©I§l¹D¿Ä¦X¯fªº¬¡©Ê Water extract of Pueraria lobata Ohwi has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. |
22 | ¤fªAMoxifloxacin«á¤§¥ð§J Shock After Oral Moxifloxacin Use |
23 | ¸¯®Ú´ö¦b©I§l¹D²ÓM®è§í¨î¤HÃþ©I§l¹D¿Ä¦X¯f¬r Ge-Gen-Tang has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. |
24 | cimicifugin¦b©I§l¹D²ÓM®è§í¨î¤HÃþ©I§l¹D¿Ä¦X¯f¬r Anti-viral effect of cimicifugin from Cimicifuga foetida inhibited human respiratory syncytial virus in HEp-2 and A549 cell lines. |
25 | ¥H FACS¤ÀªRµn²¼ö¯f¤H¶gÃä«ninnate §K¬Ì²ÓM¥X²{ÀW²v¤§ÅÜ¤Æ Frequency alterations in key innate immune cell components in peripheral blood of dengue patients detected by FACS analysis. |
26 | ¤»©M´ö¦b©I§l¹D²ÓM®è§í¨î¤HÃþ©I§l¹D¿Ä¦X¯f¬r Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract. |
27 | ¤É³Â¸¯®Ú´ö¦b©I§l¹D²ÓM®è§í¨î¤HÃþ©I§l¹D¿Ä¦X¯f¬r Sheng-Ma-Ge-Gen-Tang (Shoma-kakkon-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract. |
28 | A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate. A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate. |
29 | Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F |
30 | Ciprofloxacin¤Þ°_ÃĪ«¼ö:®×¨Ò³ø§i©M¤åÄm¦^ÅU Drug fever associated with ciprofloxacin in a cirrhotic patient with hepatocellular carcinoma |
31 | ¥Ì¯ó¼ö¤ô²ÊµÑ¨úª«¦b¤HÃþ¥]¥ÖÅÖºû¥À²ÓM§í¨î¸z¯f¬r71«¬ Water extract of Glycyrrhiza uralensis inhitibed Enterovirus 71 in a human foreskin fibroblast cell line. |
32 | 4-Methoxycinnamaldehyde ¦b¤HÃþ³ïÀù²ÓM®è§í¨î¤HÃþ©I§l¹D¿Ä¦X¯f¬r 4-Methoxycinnamaldehyde inhibited human respiratory syncytial virus in a human larynx carcinoma cell line. |
33 | ¤É³Â¸¯®Ú´ö¦b¤HÃþ¥]¥ÖÅÖºû¥À²ÓM®è§í¨î¸z¯f¬r71«¬ªº·P¬V Sheng-Ma-Ge-Gen-Tang inhibited Enterovirus 71 infection in human foreskin fibroblast cell line |
34 | ¸¯®Ú (Pueraria lobata) ¼ö¤ôµÑ¨úª«¦b¤HÃþ¥]¥ÖÅÖºû¥À²ÓM®è§í¨î¸z¯f¬r 71 «¬³y¦¨ªº²ÓM¬r©Ê A Water Extract of Pueraria Lobata Inhibited Cytotoxicity of Enterovirus 71 in a Human Foreskin Fibroblast Cell Line |
35 | Epidemiology of organophosphate pesticide poisoning in Taiwan. Epidemiology of organophosphate pesticide poisoning in Taiwan. |
36 | ¤p®ãJ´ö»P®ãJ²Ê¨m苷¦b²ÓM®è¤W§í¨îB«¬¨xª¢¯f¬r Sho-saiko-to (Xiano-Chai-Hu-Tang) and crude saikosaponins inhibit hepatitis B virus in a stable HBV-producing cell line. |
Project
NO |
YEAR ¡X Source ¡X No ¡X Type
Project Name
|
Duration |
---|---|---|
1 |
108 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST108-2320-B-037-017 ¡X 1 Ó¤H«¬
®g¤z³Â¶À´öÃĪ«°Ê¤O¾Ç¤ÎÅé¥~§Ü¯f¬r®ÄªG( )
|
2019/08/01 ~ 2020/07/31 |
2 |
106 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST105-2320-B-037-006-MY2 ¡X 1 Ó¤H«¬
¥ÌÅS®ø¬r¤¦¤Î¨ä¦³®Ä³æ¤è,¯Â¤Æª«§í¨î¸z¯f¬r71«¬ªº®ÄªG»P¾÷Âà(2/2)( )
|
2017/08/01 ~ 2018/07/31 |
3 |
105 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST105-2320-B-037-006-MY2 ¡X 1 Ó¤H«¬
¥ÌÅS®ø¬r¤¦¤Î¨ä¦³®Ä³æ¤è,¯Â¤Æª«§í¨î¸z¯f¬r71 «¬ªº®ÄªG»P¾÷Âà(1/2)( )
|
2016/08/01 ~ 2018/07/31 |
4 |
104 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST104-2320-B-037-017 ¡X 1 Ó¤H«¬
¥ÌÅS®ø¬r¶¼¥[¨ý»P¨ä¦³®Ä³æ¤è¤Î¯Â¤Æª«§í¨î¸z¯f¬r71«¬ªº®ÄªG»P¾÷Âà( )
|
2015/08/01 ~ 2016/07/31 |
5 |
103 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X NSYSUKMU103-I003-2 ¡X 2 ¾ã¦X«¬
¥H°ò¦]¹«¼Ò¦¡¤ÀªR¯ØŦÀù·L«¬®Ö¿}®Ö»Ä¥Íª«¼Ð°O¹ï¯ØŦÀù´c¤Æ½¯©µªº¼vÅT( )
|
2014/01/01 ~ 2014/12/31 |
6 |
102 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC102-2320-B-037-013 ¡X 1 Ó¤H«¬
®g¤z³Â¶À´ö»P¨ä³æ¤è¤Î¯Â¤Æª«§í¨î¸z¯f¬r71«¬ªº®ÄªG»P¾÷Âà( )
|
2013/08/01 ~ 2014/07/31 |
7 |
101 ¡X QM ÂåÀø¬ã¨spµe ¡X MR0013 ¡X
¥ÍÃħí¨î¯f¬r½Æ»s»P³J¥Õ½èÂàĶ (I)(The mechanisms of herb drugs against viral replications and protein translations (I))
|
2013/01/01 ~ 2013/12/31 |
8 |
099 ¡X QA ¥X°ê¶iתð®ÕªA°Èpµe ¡X ¡X
¬y¦¡²ÓM»ö§Ü¯f¬r¬¡©Ê¬ã¨s¤èªkªº¶}µo»PÀ³¥Î(Development and application of a flowcytometry-based antiviral method)
|
2011/05/01 ~ 2012/07/31 |
9 |
097 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC97-2320-B-037-016 ¡X 1 Ó¤H«¬
¤É³Â¸¯®Ú´ö»P¨ä¦³®Ä¦¨¤À§Ü¸z¯f¬r71«¬¬¡©Ê¤Î¾÷Âà--formononetin§Ü¸z¯f¬r71«¬ªº¬¡©Ê»P¾÷Âà( )
|
2008/08/01 ~ 2009/07/31 |
10 |
097 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X KMU-Q098003 ¡X
¥Ò°ò®ñ¦×®ÛîÇ( Methoxycinnamaldehyde )§ÜEV71¯f¬r¬¡©Ê¬ã¨s( )
|
2009/01/01 ~ 2009/12/31 |
11 |
096 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC96-2320-B-037-043 ¡X 1 Ó¤H«¬
¤É³Â¸¯®Ú´ö»P¨ä¦³®Ä¦¨¤À§Ü¸z¯f¬r71«¬¬¡©Ê¤Î¾÷Âà( )
|
2007/08/01 ~ 2008/07/31 |
12 |
096 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X ¡X
©@°Ø»Ä§ÜEV71¯f¬r¬¡©Ê¬ã¨s( )
|
2007/11/01 ~ 2008/07/31 |